---
figid: PMC3075579__10.1177_0022034510381264-fig4
figlink: /pmc/articles/PMC3075579/figure/fig4-0022034510381264/
number: F4
caption: The role of the PI3K pathway in TLR-signaling. TLR stimulation activates
  the PI3K/Akt signaling pathway. Upon TLR activation, PI3K is recruited and converts
  phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 3,4,5-trisphosphate
  (PIP3), which allows for the recruitment of signaling molecules that possess a plekstrin
  homology domain, i.e., Akt. Activation of Akt by PDK1 (Thr308) and mTORC2 (Ser473)
  results in its full activation. Activated Akt can phosphorylate GSK3-α (Ser21) or
  GSK3-β (Ser9), and this site-specific phosphorylation results in the inactivation
  of GSK3. Inactivation of GSK3 promotes increased nuclear levels of CREB (Ser133)
  that displace NF-κB p65 (Ser273) from the co-activator of transcription CBP. The
  enhanced transcriptional activity of CREB and reduced transcriptional activity of
  NF-κB p65 result in increased IL-10 production while concurrently suppressing the
  levels of pro-inflammatory cytokines. Alternately, activated Akt can inhibit GSK3
  activity indirectly through mTORC1. Active Akt inhibits the TCS2/1 complex. Once
  the TSC2/1 complex is inhibited, mTORC1 is activated, which, in turn, phosphorylates
  and activates both S6K isoforms, p70 and p85 S6K. S6K has been shown to affect the
  phosphorylation of GSK3, but it is unknown if the phosphorylation of GSK3 is due
  to a direct or indirect effect of S6K activity. Inhibition of mTORC1 with rapamycin
  attenuates phosphorylation of GSK3 and STAT3, augments NF-κB activation, and increases
  pro-inflammatory cytokine production (TNF and IL-12).
pmcid: PMC3075579
papertitle: TLR-signaling Networks.
reftext: J. Brown, et al. J Dent Res. 2011 Apr;90(4):417-427.
pmc_ranked_result_index: '126720'
pathway_score: 0.9441711
filename: 10.1177_0022034510381264-fig4.jpg
figtitle: The PI3K pathway in TLR-signaling
year: '2011'
organisms:
- Homo sapiens
ndex: 561b2e22-deff-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3075579__10.1177_0022034510381264-fig4.html
  '@type': Dataset
  description: The role of the PI3K pathway in TLR-signaling. TLR stimulation activates
    the PI3K/Akt signaling pathway. Upon TLR activation, PI3K is recruited and converts
    phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 3,4,5-trisphosphate
    (PIP3), which allows for the recruitment of signaling molecules that possess a
    plekstrin homology domain, i.e., Akt. Activation of Akt by PDK1 (Thr308) and mTORC2
    (Ser473) results in its full activation. Activated Akt can phosphorylate GSK3-α
    (Ser21) or GSK3-β (Ser9), and this site-specific phosphorylation results in the
    inactivation of GSK3. Inactivation of GSK3 promotes increased nuclear levels of
    CREB (Ser133) that displace NF-κB p65 (Ser273) from the co-activator of transcription
    CBP. The enhanced transcriptional activity of CREB and reduced transcriptional
    activity of NF-κB p65 result in increased IL-10 production while concurrently
    suppressing the levels of pro-inflammatory cytokines. Alternately, activated Akt
    can inhibit GSK3 activity indirectly through mTORC1. Active Akt inhibits the TCS2/1
    complex. Once the TSC2/1 complex is inhibited, mTORC1 is activated, which, in
    turn, phosphorylates and activates both S6K isoforms, p70 and p85 S6K. S6K has
    been shown to affect the phosphorylation of GSK3, but it is unknown if the phosphorylation
    of GSK3 is due to a direct or indirect effect of S6K activity. Inhibition of mTORC1
    with rapamycin attenuates phosphorylation of GSK3 and STAT3, augments NF-κB activation,
    and increases pro-inflammatory cytokine production (TNF and IL-12).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDK1
  - OPN1LW
  - TREH
  - MLST8
  - MAPKAP1
  - NFKB1
  - IL12A
  - IL12B
  - AKT1
  - AKT2
  - MYD88
  - PTEN
  - CREB1
  - MTOR
  - TRAF6
  - TNF
  - AKT3
  - GSK3B
  - IL10
  - CREB3L2
  - CREB3L3
  - IL1B
  - RICTOR
  - MAL
  - IRF3
  - CREB3
  - RHEB
  - NR2C2
  - CREB3L4
  - GSK3A
  - CREB3L1
  - ATF1
  - IRAK1
  - CREB5
  - CREM
  - ATF2
  - Rapamycin
genes:
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: CBP
  symbol: CBP
  source: hgnc_prev_symbol
  hgnc_symbol: OPN1LW
  entrez: '5956'
- word: TRE
  symbol: TRE
  source: hgnc_alias_symbol
  hgnc_symbol: TREH
  entrez: '11181'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: IL-12;
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12A
  entrez: '3592'
- word: IL-12;
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12B
  entrez: '3593'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: 'TNF-a:'
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: IL-10
  symbol: IL-10
  source: hgnc_alias_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: IL-1B
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: Mal
  symbol: MAL
  source: hgnc_symbol
  hgnc_symbol: MAL
  entrez: '4118'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: TAK1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: IRAK
  symbol: IRAK
  source: hgnc_alias_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
chemicals:
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases: []
figid_alias: PMC3075579__F4
redirect_from: /figures/PMC3075579__F4
figtype: Figure
---
